KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Return on Sales (2016 - 2025)

Historic Return on Sales for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to 0.17%.

  • Medpace Holdings' Return on Sales fell 100.0% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.19% for FY2024, which is 400.0% up from last year.
  • According to the latest figures from Q3 2025, Medpace Holdings' Return on Sales is 0.17%, which was down 100.0% from 0.15% recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Return on Sales ranged from a high of 0.22% in Q4 2024 and a low of 0.13% during Q2 2023
  • Over the past 5 years, Medpace Holdings' median Return on Sales value was 0.17% (recorded in 2024), while the average stood at 0.17%.
  • Per our database at Business Quant, Medpace Holdings' Return on Sales plummeted by -300bps in 2021 and then surged by 600bps in 2024.
  • Quarter analysis of 5 years shows Medpace Holdings' Return on Sales stood at 0.16% in 2021, then rose by 7bps to 0.17% in 2022, then decreased by -10bps to 0.16% in 2023, then skyrocketed by 39bps to 0.22% in 2024, then dropped by -23bps to 0.17% in 2025.
  • Its last three reported values are 0.17% in Q3 2025, 0.15% for Q2 2025, and 0.21% during Q1 2025.